PGNY Stock Analysis: Buy, Sell, or Hold?
PGNY - Progyny, Inc. Common Stock
$31.45
-0.08 (-0.25%)
▼
5d:
+2.24%
30d:
+1.68%
90d:
+66.31%
BUY
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 06, 2026
1d
Get Alerted When PGNY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PGNY shows positive signals but monitor for confirmation. Market pricing in 7.5% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: PGNY shows positive signals but monitor for confirmation. Market pricing in 7.5% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.02
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$21.74
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PGNY is currently trading at $31.45, which is considered fair relative to its 30-day fair value range of $28.47 to $32.10. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.0) compared to its historical average (11.3). At these levels, the market is pricing in 7.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PGNY is in a strong uptrend. Immediate support is located at $29.93, while resistance sits at $32.70.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PGNY is in a strong uptrend. Immediate support is located at $29.93, while resistance sits at $32.70.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$28.47 -
$32.10
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($34.00)
- NEUTRAL: Trading at premium valuation - market expects 7.5% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$28.47 -
$32.10
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$29.93
Resistance Level
$32.70
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.03
Wall Street Target
$34.00
(+7.8%)
Revenue Growth (YoY)
1.4%
Earnings Growth (YoY)
70.6%
Profit Margin
5.2%
Valuation Premium vs History
+7.5% premium
PE vs Historical
14.0 vs 11.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.5%
(market-implied from PE analysis)
1-Year Target
$33.89
(+8%)
2-Year Target
$36.44
(+16%)
3-Year Target
$39.17
(+24%)
3-Yr Target (if PE normalizes)
(PE: 14→11)
PE COMPRESSION
$31.55
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 9.3%)
$60.83
(+93%)
Base:
(SPY PE: 14.0, Growth: 9.3%)
$41.16
(+31%)
Bear:
(PE: 11.3, Growth: 9.3%)
$33.16
(+5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (40x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 40.43 | Current EPS (TTM): $0.77
Bull Case
$68.49
(+117%)
Analyst growth 100.0%, PE expands to 44.5
Base Case
$62.26
(+98%)
Market implied 100.0%, PE stable at 40.4
Bear Case
$21.17
(-33%)
Severe decline -20.0%, PE contracts to 34.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 04, 2026 10:46 AM ET
Data refreshes hourly during market hours. Next update: 11:46 AM
Data refreshes hourly during market hours. Next update: 11:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGNY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Allison Swartz
SELL
599 shares
2026-03-04
Allison Swartz
SELL
4657 shares
2026-03-03
Allison Swartz
SELL
2199 shares
2026-03-02
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$114 | 52 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 49 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$343 | 47 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 55 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$408 | 57 HOLD |
Advanced PGNY Option Strategies
Professional options setups generated by AI based on today's PGNY price and gamma walls.
